Coppell Advisory Solutions’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-63
| Closed | -$31 | – | 1173 |
|
|
2024
Q4 | $31 | Hold |
63
| – | – | ﹤0.01% | 1951 |
|
|
2024
Q3 | $58 | Hold |
63
| – | – | ﹤0.01% | 1829 |
|
|
2024
Q2 | $63 | Buy |
+63
| New | +$63 | ﹤0.01% | 1748 |
|
|
2023
Q4 | $69 | Sell |
63
-99
| -61% | -$108 | ﹤0.01% | 1665 |
|
|
2023
Q3 | $190 | Buy |
162
+68
| +72% | +$80 | ﹤0.01% | 1116 |
|
|
2023
Q2 | $132 | Buy |
+94
| New | +$132 | ﹤0.01% | 1360 |
|
|
2023
Q1 | – | Sell |
-162
| Closed | -$190 | – | 690 |
|
|
2022
Q4 | $190 | Buy |
+162
| New | +$190 | ﹤0.01% | 1118 |
|